[go: up one dir, main page]

DE69935662D1 - Mittel zur prävention/behandlung entzündlicher darmerkrankungen - Google Patents

Mittel zur prävention/behandlung entzündlicher darmerkrankungen

Info

Publication number
DE69935662D1
DE69935662D1 DE69935662T DE69935662T DE69935662D1 DE 69935662 D1 DE69935662 D1 DE 69935662D1 DE 69935662 T DE69935662 T DE 69935662T DE 69935662 T DE69935662 T DE 69935662T DE 69935662 D1 DE69935662 D1 DE 69935662D1
Authority
DE
Germany
Prior art keywords
endurance
inflammatory
prevention
treatment
preventives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69935662T
Other languages
English (en)
Inventor
Takehiro Yatomi
Shigekazu Nagata
Takashi Suda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osaka Bioscience Institute
Mochida Pharmaceutical Co Ltd
Original Assignee
Osaka Bioscience Institute
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osaka Bioscience Institute, Mochida Pharmaceutical Co Ltd filed Critical Osaka Bioscience Institute
Application granted granted Critical
Publication of DE69935662D1 publication Critical patent/DE69935662D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Window Of Vehicle (AREA)
  • Surgical Instruments (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69935662T 1998-02-06 1999-02-05 Mittel zur prävention/behandlung entzündlicher darmerkrankungen Expired - Lifetime DE69935662D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2549298 1998-02-06
PCT/JP1999/000496 WO1999039737A1 (fr) 1998-02-06 1999-02-05 Medicaments pour prevenir/traiter la maladie intestinale inflammatoire

Publications (1)

Publication Number Publication Date
DE69935662D1 true DE69935662D1 (de) 2007-05-10

Family

ID=12167564

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69935662T Expired - Lifetime DE69935662D1 (de) 1998-02-06 1999-02-05 Mittel zur prävention/behandlung entzündlicher darmerkrankungen

Country Status (6)

Country Link
US (1) US6562342B1 (de)
EP (1) EP1059089B1 (de)
AT (1) ATE357931T1 (de)
CA (1) CA2319421A1 (de)
DE (1) DE69935662D1 (de)
WO (1) WO1999039737A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999039737A1 (fr) * 1998-02-06 1999-08-12 Mochida Pharmaceutical Co., Ltd. Medicaments pour prevenir/traiter la maladie intestinale inflammatoire
US20090209867A1 (en) * 2005-04-18 2009-08-20 Cha Min Tang Method for rapid screening of mad cow disease and other transmissible spongiform encephalopathies
US20090196868A1 (en) * 2007-09-06 2009-08-06 Apogenix Gmbh Methods and compositions for preventing radiation-induced pneumonitis
EP3286221A1 (de) * 2015-04-22 2018-02-28 INSERM - Institut National de la Santé et de la Recherche Médicale Verfahren und pharmazeutische zusammensetzungen zur behandlung von th17-vermittelten erkrankungen
TW202308605A (zh) * 2021-07-19 2023-03-01 日商明治控股股份有限公司 用於炎症性腸疾病之預防或改善之組合物、以及用於腸內細菌叢調節之組合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08127594A (ja) 1993-11-10 1996-05-21 Mochida Pharmaceut Co Ltd Fas抗原に結合する新規蛋白質およびそれをコードするDNA
US6096312A (en) * 1995-06-30 2000-08-01 Mochida Pharmaceutical Co., Ltd. Agent for suppressing a reduction of CD4+ lymphocytes
CN1196733A (zh) 1995-06-30 1998-10-21 持田制药株式会社 抗Fas配体抗体和利用抗Fas配体抗体的测定方法
JP4339405B2 (ja) 1996-10-31 2009-10-07 持田製薬株式会社 予防・治療剤
WO1999039737A1 (fr) * 1998-02-06 1999-08-12 Mochida Pharmaceutical Co., Ltd. Medicaments pour prevenir/traiter la maladie intestinale inflammatoire

Also Published As

Publication number Publication date
EP1059089B1 (de) 2007-03-28
US6562342B1 (en) 2003-05-13
EP1059089A4 (de) 2005-01-19
EP1059089A1 (de) 2000-12-13
CA2319421A1 (en) 1999-08-12
ATE357931T1 (de) 2007-04-15
WO1999039737A1 (fr) 1999-08-12

Similar Documents

Publication Publication Date Title
DE69934010D1 (de) Zusammensetzungen zur behandlung von chlamydiale assozierten krankheiten
DE60133029D1 (de) Mittel zur prävention oder behandlung von psoriasi
TR200102817T2 (tr) Antiinflamatuar ajanlar olarak faydalı bileşikler
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
ATE123943T1 (de) Mittel zur behandlung und vorbeugung von bauchentzündungen, die als wirkstoff zink-l- carnosin-salze oder -komplexe enthalten.
PE14199A1 (es) Agonistas de 5-ht1f
BRPI0415409A (pt) uso de efetuadores de ciclases de glutaminila e glutamato
DK1212422T3 (da) Humane CTLA-4-antistoffer og anvendelserne deraf
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
TR200002965T2 (tr) Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
ATE310088T1 (de) Behandlung und nachweis von staphylokokkeninfektionen
PT1056454E (pt) Utilizacao de compostos macrolido para o tratamento do glaucoma
EP0932613A4 (de) Expressionsblockierung von virulenten faktoren in s. aureus
EE200300064A (et) Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine
DE69729183T2 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
DE69935662D1 (de) Mittel zur prävention/behandlung entzündlicher darmerkrankungen
DK1763339T3 (da) Orale antimikrobielle farmaceutiske præparater
ID25478A (id) Agonis 5-ht1f
EA200400670A1 (ru) Фармацевтические композиции, содержащие 3,4-пропинопергидропурины, и их применение для блокирования нейронной передачи
ATE420852T1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
EP1496742A4 (de) Verwendung von nichtantibakteriellen tetrazyklin-analoga und ihren formulierungen für die behandlung von bakteriellen exotoxinen

Legal Events

Date Code Title Description
8332 No legal effect for de